These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15572418)

  • 1. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism.
    Wystrychowski A; Pidasheva S; Canaff L; Chudek J; Kokot F; Wiecek A; Hendy GN
    J Clin Endocrinol Metab; 2005 Feb; 90(2):864-70. PubMed ID: 15572418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
    J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
    D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
    Bai M; Pearce SH; Kifor O; Trivedi S; Stauffer UG; Thakker RV; Brown EM; Steinmann B
    J Clin Invest; 1997 Jan; 99(1):88-96. PubMed ID: 9011580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
    Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
    Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.
    Zajickova K; Vrbikova J; Canaff L; Pawelek PD; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2616-23. PubMed ID: 17473068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    D'Souza-Li L; Canaff L; Janicic N; Cole DE; Hendy GN
    Hum Mutat; 2001 Nov; 18(5):411-21. PubMed ID: 11668634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly.
    Pidasheva S; Grant M; Canaff L; Ercan O; Kumar U; Hendy GN
    Hum Mol Genet; 2006 Jul; 15(14):2200-9. PubMed ID: 16740594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene.
    Tõke J; Czirják G; Patócs A; Enyedi B; Gergics P; Csákváry V; Enyedi P; Tóth M
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):385-92. PubMed ID: 17555508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional analysis of novel calcium-sensing receptor gene mutation in familial hypocalciuric hypercalcemia.
    Nanjo K; Nagai S; Shimizu C; Tajima T; Kondo T; Miyoshi H; Yoshioka N; Koike T
    Endocr J; 2010; 57(9):787-92. PubMed ID: 20697181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.
    Lietman SA; Tenenbaum-Rakover Y; Jap TS; Yi-Chi W; De-Ming Y; Ding C; Kussiny N; Levine MA
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4372-9. PubMed ID: 19789209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
    Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
    Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism.
    Kobayashi M; Tanaka H; Tsuzuki K; Tsuyuki M; Igaki H; Ichinose Y; Aya K; Nishioka N; Seino Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2716-9. PubMed ID: 9253359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder.
    Diaz-Thomas A; Cannon J; Iyer P; Al-Maawali A; Fazalullah M; Diamond F; Mueller OT; Root AW; Alyaarubi S
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):851-6. PubMed ID: 24854525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
    Pearce SH; Trump D; Wooding C; Besser GM; Chew SL; Grant DB; Heath DA; Hughes IA; Paterson CR; Whyte MP
    J Clin Invest; 1995 Dec; 96(6):2683-92. PubMed ID: 8675635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families.
    Schwarz P; Larsen NE; Lønborg Friis IM; Lillquist K; Brown EM; Gammeltoft S
    Scand J Clin Lab Invest; 2000 May; 60(3):221-7. PubMed ID: 10885494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia.
    Cetani F; Lemmi M; Cervia D; Borsari S; Cianferotti L; Pardi E; Ambrogini E; Banti C; Brown EM; Bagnoli P; Pinchera A; Marcocci C
    Eur J Endocrinol; 2009 Mar; 160(3):481-9. PubMed ID: 19073830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.